<DOC>
	<DOCNO>NCT00209859</DOCNO>
	<brief_summary>To investigate whether cyclosporine , add methotrexate steroid , increase possibility inflammatory management early disease ; furthermore investigate possible steroid-sparing effect cyclosporine patient recently diagnose rheumatoid arthritis .</brief_summary>
	<brief_title>Methotrexate Cyclosporine Treatment Early Rheumatoid Arthritis</brief_title>
	<detailed_description>Design : Multicentre , prospective , randomised , double-blind study parallel design . Selection patient : Patients recently diagnose rheumatoid arthritis ( le 6 month persistent synovitis ) .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<criteria>Synovitis least 2 joint . Compliance ACR criterion RA . Duration 6 month ( first anamnestic nontraumatic synovitis least 6 week â€™ duration ) . Informed consent . Age le 18 year 75 year Lack cooperability . Previous treatment DMARD Corticosteroid treatment precede 4 week . Contra indication treatment ( await recommendation Novartis ) Previous present malignant premalignant disease Poorly regulate hypertension Impaired renal function Immuno defective disease , include HIV Cardiac pulmonary insufficiency Serious arteriosclerosis Serious granulocytopenia thrombocytopenia Impaired liver function ( liver enzyme twice high normal limit ) . Alcohol consumption 3 drink week . Poorly control epilepsy Lack contraception fertile patient Pregnancy lactation Psoriasis Poorly regulate diabetes Anticoagulant treatment Known allergy medicine Medicamental interactions Other inflammatory rheumatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>